Patients
Labour, the NHS, and life sciences: Partnerships and people
The United Kingdom this morning woke to landslide poll results: …
19711 items found
News
NHS will take more than one term to fix, says Streeting
While the headlines are all about the Labour landslide in the UK …
Oncology
Single-cell multi-omics and oncological potential
Just like people, no two cancer cells are alike. And now, scientists …
R&D
Innovation in generics: Increased efficiency through peptide API synthesis expertise
With the healthcare landscape continually evolving, the generic …
News
Private equity firms ‘eyeing $20bn for Sanofi consumer unit’
Private equity firms Bain Capital and Cinven are reported to be …
News
Pieris loses Servier as partner for cancer immunotherapies
Pieris Pharmaceuticals’ long-standing immuno-oncology alliance with …
News
Judge kicks out another Medicare price negotiation challenge
A Connecticut federal judge has sided with the US Department of …
News
Survey reveals heavy burden of chronic hand eczema
People with chronic hand eczema (CHE) have reported the serious …
Digital
Changing Faces: Digital and supplier hires from April 2024
Finally, we wrap up the belated April hires round-ups with our …
News
US govt gives $176m to Moderna for bird flu vaccine
The US government has signed a $176 million deal with Moderna to …
News
Deep learning AI predicts response to cancer treatment
Artificial intelligence software developed by Pangea Biomed can …
News
UK gets guidance on synthetic human embryos for research
A new code of practice has been drawn up in the UK to try to make …
News
Lawmakers seek answers on Pfizer, Lilly telehealth moves
US Senators are concerned that Pfizer and Eli Lilly's recent forays into direct-to-consumer distribution of medicines via telehealth platforms could violate federal anti-kickback laws.
Sales & Marketing
Enabling site success: Key insights to reducing burden and i...
Investigator sites are essential for successful execution of clinical trials – ensuring studies are conducted ethically, safely, and in compliance with regulatory standards.
Sales & Marketing
Deep Dive: Commercialisation 2024
In this issue, we unpack Ozempic’s rise to superstar status and the risks associated with its off-label use.
Digital
Sponsored
How to deal with fragmented data - A $12.9 million challenge
In the age of AI, large data sets – like the treasure trove of customer data most biopharma companies are sitting on – are an invaluable asset.
Digital
Access to genomic surveillance: Open science and public heal...
The pandemic served as a catalyst for a revolution in genomic surveillance for tracking pathogens.
Sales & Marketing
Sponsored
Launch Excellence: Moments of Truth
The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns, creating challenges and opportunities.
R&D
Partner Content
BIO-Europe's 30th Anniversary Landmark Event in Stockholm
BIO-Europe™ celebrates 30 years of facilitating partnerships this Fall. In 1994, BIO-Europe launched with the mission to drive biotech innovation and
R&D
Partner Content
8th Dermatology Drug Development Summit
Industry’s Destination to Discover & Develop Best-In-Class Drugs for Immuno-Inflammatory Skin Disease
